Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 2 Trials for Cediranib (DB04849)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02498613A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsTreatment